Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non–COVID-19 Sepsis but Carries a Moderately Increased Risk of Death
- 1 June 2020
- journal article
- letter
- Published by Wolters Kluwer Health in Hypertension
- Vol. 75 (6) , E15-E16
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Clinical Characteristics of Covid-19 in ChinaNew England Journal of Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?The Lancet Respiratory Medicine, 2020
- Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19Journal of Travel Medicine, 2020
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?Journal Of Hypertension, 2020
- Sex-based differences in ED management of critically ill patients with sepsis: a nationwide cohort studyIntensive Care Medicine, 2020